Citations

Mayo Clinic

Showing 10 of 108522 citations.

Teaching Neuro Images : Hyperdense posterior cerebral artery sign
Capampangan, Dan J., Lee-Ianotti, Joyce K., Riordan, Katherine C., Kramer, Christopher L.

Neurology | November 10, 2014 | Volume: 83 | Issue: 20 | Pages: No page available

10.1212/wnl.0000000000000976 | PMID 25385834 Get It

Short Myelitis Lesions in Aquaporin-4-IgG–Positive Neuromyelitis Optica Spectrum Disorders
Flanagan, Eoin P. , Weinshenker, Brian G. , Krecke, Karl N. , Lennon, Vanda A. , Lucchinetti, Claudia F. , McKeon, Andrew , Wingerchuk, Dean M. , Shuster, Elizabeth A., Jiao, Yujuan , Horta, Erika , Pittock, Sean J. , Horta, Erika S, Pittock, S J , Flanagan, E P , Weinshenker, Brian G , McKeon, Andrew

JAMA Neurology | November 10, 2014 | Volume: 72 | Issue: 1 | Pages: 81

10.1001/jamaneurol.2014.2137 | PMID 25384099 Get It

Time Trends in Incidence, Clinical Features, and Cardiovascular Disease in Ankylosing Spondylitis Over Three Decades: A Population‐Based Study
Wright, Kerry , Crowson, Cynthia S. , Michet, Clement J. , Matteson, Eric L. , Wright, Kerry A

Arthritis Care & Research | November 10, 2014 | Volume: 67 | Issue: 6 | Pages: 836-841

10.1002/acr.22512 | PMID 25384671 Get It

ObjectiveTo determine trends in the incidence and clinical presentation of ankylosing spondylitis (AS), the incidence of cardiovascular disease (CVD), and cardiovascular (CV) risk factors among patients with AS and compare the observed incidence of CVD with that predicted by the Framingham Risk Score (FRS).MethodsA population‐based inception cohort of residents of Olmsted County, Minnesota age ≥18 years who fulfilled Modified New York Criteria for AS in 1980–2009 was assembled. Clinical features at presentation were recorded. Age‐ and sex‐adjusted incidence rates and survival were estimated. Incident CVD and CV risk factors were identified. The 10‐year CVD risk was calculated using the FRS. Standardized incidence ratios (ratios of observed CVD in AS to that predicted by the FRS) were calculated.ResultsEighty‐six patients were diagnosed with AS over the study period with an age‐ and sex‐adjusted incidence of 3.1 per 100,000 (95% confidence interval [95% CI] 2.5–3.8). The mean age at diagnosis was 35 years (range 19–69 years). Inflammatory back pain, seen in 90% of patients, was the most common presenting manifestation. The 10‐year mean ± SD cumulative incidence of CVD was 15.8% ± 6.1%, three times higher than the predicted events based on the FRS (standardized incidence ratio 3.01, 95% CI 1.35–6.69; P = 0.007). Overall survival was similar to the general population.ConclusionAS occurs in approximately 3 persons per 100,000 per year. Clinical features, extraarticular manifestations, and interval from symptom onset to diagnosis have remained constant in this population over the study period. The CVD risk in these patients is higher than expected and underestimated by the FRS.
Control of nanoparticle penetration into biofilms through surface design
Yeh, Yi‐Cheun , Giri, Karuna, Mout, Rubul , Landis, Ryan F., Prakash, Y. S. , Li, Xiaoning , Rotello, Vincent M. , Prakash, Y S

Chemical Communications | November 10, 2014 | Volume: 51 | Issue: 2 | Pages: 282-285

10.1039/c4cc07737g | PMID 25407407 Get It

Cationic quantum dots effectively penetrate biofilms, providing insight for targeting and imaging applications.
Clinical course and prognosis of non‐secretory multiple myeloma
Kumar, Shaji , Dispenzieri, Angela , Greenberg, Alexandra J. , Kyle, Robert A. , Lacy, Martha Q. , Chawla, Sagar S, Larson, Dirk R. , Chawla, Sagar , Gertz, Morie A. , Rajkumar, S. Vincent , Dispenzieri, Angela

European Journal of Haematology | November 10, 2014 | Volume: 95 | Issue: 1 | Pages: 57-64

10.1111/ejh.12478 | PMID 25382589 Get It

Abstract Objective To determine the prognosis of patients with non‐secretory myeloma. Methods We studied 124 patients diagnosed with multiple myeloma who had no monoclonal protein detected on serum and urine immunofixation at diagnosis and on all subsequent follow‐up testing (non‐secretory myeloma). The overall survival ( OS ) of patients with non‐secretory myeloma was compared with 6953 patients with typical myeloma seen during the same time period in whom a monoclonal protein was detected at the time of diagnosis. Results One hundred and twenty‐four patients met criteria for non‐secretory multiple myeloma. The median follow‐up was 102 months (range, 1–204 months). The median progression‐free survival with initial therapy was 28.6 months, and the median OS was 49.3 months. There was a significant improvement in OS since 2001; median survival 43.8 months (prior to 2001) vs. 99.2 months (2001–2012), P < 0.001. OS was superior in patients with a normal baseline FLC ratio ( n = 10) compared to patients with an abnormal ratio ( n = 19), medians not reached in both groups. Prior to 2001, OS was similar in non‐secretory myeloma ( n = 86) and secretory myeloma ( n = 4011), median 3.6 vs. 3.5 yr, respectively, P = 0.63. However, among patients diagnosed between 2001 and 2012, OS was superior in non‐secretory myeloma ( n = 36) compared to secretory myeloma ( n = 2942), median 8.3 vs. 5.4 yr, respectively, P = 0.03. Conclusions Non‐secretory myeloma is an uncommon subtype of multiple myeloma. In the last decade, there has been an improvement in the survival of non‐secretory myeloma and appears superior to secretory myeloma.
Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia
Ojha, Juhi, Secreto, Charla, Rabe, Kari G. , Dyke, Daniel L. Van , Braggio, Esteban , Kortüm, K. Martin , Slager, Susan L. , Shanafelt, Tait D. , Fonseca, Rafaël , Kay, Neil E. , Chaffee, Kari G. , Braggio, Esteban

British Journal of Haematology | November 10, 2014 | Volume: 169 | Issue: 3 | Pages: 445-448

10.1111/bjh.13211 | PMID 25382417 Get It

Combination of a fillet flap, free tissue transfer, and autologous tissue grafts in pelvic reconstruction following retroperitoneal sarcoma: A case report
Saksena, Anshuman, Aho, Johnathon M. , Winocour, Sebastian, Maricevich, Renata L., Senchenkov, Alex, Rose, Peter S. , Leibovich, Bradley C. , Zietlow, Scott P., Saint‐Cyr, Michel, Aho, Johnathon, Maricevich, Renata, Rose, Peter, Leibovich, Bradley, Zietlow, Scott

Microsurgery | November 8, 2014 | Volume: 35 | Issue: 4 | Pages: 320-323

10.1002/micr.22352 | PMID 25382698 Get It

The resection of large pelvic tumors is challenging due to their infiltrative nature into multiple structures and organ systems. In this report, we describe the use of multiple vascularized and nonvascularized spare parts to reconstruct a pelvic defect in a patient with a uniquely large pelvic sarcoma invading the spinal canal. A 39‐year‐old Caucasian female who presented with a large retroperitoneal sarcoma where the tumor encased the left ureter, kidney, colon, and external iliac vessels and invaded the L3‐S1 vertebral bodies. An extensive hemipelvectomy and reconstruction was performed over two days. A free thigh and leg fillet flap together with ipsilateral fibula flap, based on the superficial femoral artery and venae comitantes, was used for spinal reinforcement as well as abdominal and pelvic wall reconstruction. The postoperative course was uneventful without complications, no flap compromise or wound healing problems. After a follow‐up period of 4 months, the patient had no complications and returned to activities of daily living with mild limitations. The success of this flap procedure shows the practicality and usefulness of using the full spectrum of tissue transfer for the purposes of a large pelvic reconstruction. © 2014 Wiley Periodicals, Inc. Microsurgery 35:320–323, 2015.
Mutant SNAP25B causes myasthenia, cortical hyperexcitability, ataxia, and intellectual disability
Shen, Xin‐Ming , Selcen, Duygu , Brengman, Joan M., Engel, Andrew G. , Brengman, Joan

Neurology | November 8, 2014 | Volume: 83 | Issue: 24 | Pages: 2247-2255

10.1212/wnl.0000000000001079 | PMID 25381298 Get It

Comment on “Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2”
Fang, Boyan , Lennon, Vanda A.

The Journal of Immunology | November 7, 2014 | Volume: 193 | Issue: 10 | Pages: 4755-4755

10.4049/jimmunol.1402224 | PMID 25381354 Get It

Smoking is not associated with recurrence and retreatment of intracranial aneurysms after endovascular coiling
Brinjikji, Waleed , Lingineni, Ravi K., Gu, Chris N., Cloft, Harry J. , Ulsh, Lauren, Koeller, Kristen, Kallmes, David F. , Lanzino, Giuseppe

Journal of Neurosurgery | November 7, 2014 | Volume: 122 | Issue: 1 | Pages: 95-100

10.3171/2014.10.jns141035 | PMID 25380112 Get It

OBJECT Tobacco smoking is one of the most important risk factors for the formation of intracranial aneurysms and for aneurysmal subarachnoid hemorrhages. Smoking has also been suggested to contribute to the recurrence of aneurysms after endovascular coiling. To improve the understanding of the impact of smoking on long-term outcomes after coil embolization of intracranial aneurysms, the authors studied a consecutive contemporary series of patients treated at their institution. The aims of this study were to determine whether smoking is an independent risk factor for aneurysm recurrence and retreatment after endovascular coiling. METHODS All patients who had received an intrasaccular coil embolization of an intracranial aneurysm, who had undergone a follow-up imaging exam at least 6 months later, and whose smoking history had been recorded from January 2005 through December 2012 were included in this study. Patients were stratified according to smoking status into 3 groups: 1) never a smoker, 2) current smoker (smoked at the time of treatment), and 3) former smoker (quit smoking before treatment). The 2 primary outcomes studied were aneurysm recurrence and aneurysm retreatment after treatment for endovascular aneurysms. Kruskal-Wallis and chi-square tests were used to test statistical significance of differences in the rates of aneurysm recurrence, retreatment, or of both among the 3 groups. A multivariate logistic regression analysis controlling for smoking status and for several characteristics of the aneurysm was also performed. RESULTS In total, 384 patients with a combined total of 411 aneurysms were included in this study. The aneurysm recurrence rate was not significantly associated with smoking: both former smokers (OR 1.00, 95% CI 0.61–1.65; p = 0.99) and current smokers (OR 0.58, 95% CI 0.31–1.09; p = 0.09) had odds of recurrence that were similar to those who were never smokers. Former smokers (OR 0.78, 95% CI 0.46–1.35; p = 0.38) had odds of retreatment similar to those of never smokers, and current smokers had a lower odds of undergoing retreatment (OR 0.44, 95% CI 0.21–0.91; p = 0.03) than never smokers. Moreover, an analysis adjusting for aneurysm rupture, diameter, and initial occlusion showed that former smokers (OR 0.65, 95% CI 0.33–1.28; p = 0.21) and current smokers (OR 1.04, 95% CI 0.60–1.81; p = 0.88) had odds of aneurysm recurrence similar to those who were never smokers. Adjusting the analysis for aneurysm rupture, diameter, and occlusion showed that both former smokers (OR 0.49, 95% CI 0.23–1.05; p = 0.07) and current smokers (OR 0.82, 95% CI 0.46–1.46; p = 0.50) had odds of retreatment similar to those of patients who were never smokers. CONCLUSIONS The results show that smoking was not an independent risk factor for aneurysm recurrence and aneurysm retreatment among patients receiving endovascular treatment for intracranial aneurysms at the authors' institution. Nonetheless, patients with intracranial aneurysms should continue to be counseled about the risks of tobacco smoking.